Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials.

BMJ Open · 2019 · PMC6773352 · PMID 31575567

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

26 When this study was removed in a sensitivity analysis, heterogeneity decreased and the observed risk increase became nominally significant (1.30, 1.06 to 1.58).

also in 7,732 other papers

borderline significantno p-value reported

Differences between primary prevention and CAD trials were significant or borderline significant for all efficacy outcomes except stroke ( online supplementary eFigures 2–7 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.